Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 87

1.

Systematic review on the proteomic profile of Mycobacterium tuberculosis exposed to drugs.

Campanerut-Sá PAZ, Ghiraldi-Lopes LD, Meneguello JE, Teixeira JJV, Scodro RBL, Siqueira VLD, Svidzinski TIE, Pavan FR, Cardoso RF.

Proteomics Clin Appl. 2017 Jun 19. doi: 10.1002/prca.201600077. [Epub ahead of print] Review.

PMID:
28627738
2.

Moxifloxacin is an effective and safe candidate agent for tuberculosis treatment: a meta-analysis.

Xu P, Chen H, Xu J, Wu M, Zhu X, Wang F, Chen S, Xu J.

Int J Infect Dis. 2017 Jul;60:35-41. doi: 10.1016/j.ijid.2017.05.003. Epub 2017 May 8. Review.

3.
4.

Comparison of Pathogen Eradication Rate and Safety of Anti-Bacterial Agents for Bronchitis: A Network Meta-Analysis.

Wang J, Xu H, Wang D, Li M.

J Cell Biochem. 2017 Feb 23. doi: 10.1002/jcb.25951. [Epub ahead of print]

PMID:
28230273
5.

Meta-analysis of the efficacy of moxifloxacin in treating Mycoplasma genitalium infection.

Li Y, Le WJ, Li S, Cao YP, Su XH.

Int J STD AIDS. 2017 Jan 1:956462416688562. doi: 10.1177/0956462416688562. [Epub ahead of print]

PMID:
28118803
6.

Minimum inhibitory concentration distributions for Mycobacterium avium complex-towards evidence-based susceptibility breakpoints.

Schön T, Chryssanthou E.

Int J Infect Dis. 2017 Feb;55:122-124. doi: 10.1016/j.ijid.2016.12.027. Epub 2017 Jan 6.

7.

Fluoroquinolones or macrolides in combination with β-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis.

Vardakas KZ, Trigkidis KK, Falagas ME.

Clin Microbiol Infect. 2017 Apr;23(4):234-241. doi: 10.1016/j.cmi.2016.12.002. Epub 2016 Dec 10. Review.

PMID:
27965070
8.

Perioperative Antibiotics to Prevent Acute Endophthalmitis after Ophthalmic Surgery: A Systematic Review and Meta-Analysis.

Huang J, Wang X, Chen X, Song Q, Liu W, Lu L.

PLoS One. 2016 Nov 8;11(11):e0166141. doi: 10.1371/journal.pone.0166141. eCollection 2016.

9.

[Mycoplasma genitalium].

Alcaraz I, Dupin N, Janier M, Derancourt C, Milpied B, Bertolotti A; section MST de la SFD.

Ann Dermatol Venereol. 2016 Nov;143(11):718-719. doi: 10.1016/j.annder.2016.09.006. Epub 2016 Oct 20. French. No abstract available.

PMID:
27773499
10.

2016 European guideline on Mycoplasma genitalium infections.

Jensen JS, Cusini M, Gomberg M, Moi H.

J Eur Acad Dermatol Venereol. 2016 Oct;30(10):1650-1656. doi: 10.1111/jdv.13849. Epub 2016 Aug 9. Review.

PMID:
27505296
11.

Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysis.

Xin Y, Manson J, Govan L, Harbour R, Bennison J, Watson E, Wu O.

BMC Gastroenterol. 2016 Jul 26;16(1):80. doi: 10.1186/s12876-016-0491-7. Review.

12.

Moxifloxacin and gatifloxacin for initial therapy of tuberculosis: a meta-analysis of randomized clinical trials.

Ruan Q, Liu Q, Sun F, Shao L, Jin J, Yu S, Ai J, Zhang B, Zhang W.

Emerg Microbes Infect. 2016 Feb 24;5:e12. doi: 10.1038/emi.2016.12.

13.

Effects of Fluroquinolones in Newly Diagnosed, Sputum-Positive Tuberculosis Therapy: A Systematic Review and Network Meta-Analysis.

Li D, Wang T, Shen S, Cheng S, Yu J, Zhang Y, Zhang C, Tang H.

PLoS One. 2015 Dec 15;10(12):e0145066. doi: 10.1371/journal.pone.0145066. eCollection 2015. Review.

14.

Efficacy of Antimicrobial Therapy for Mycoplasma genitalium Infections.

Manhart LE, Jensen JS, Bradshaw CS, Golden MR, Martin DH.

Clin Infect Dis. 2015 Dec 15;61 Suppl 8:S802-17. doi: 10.1093/cid/civ785. Review.

PMID:
26602619
15.

WITHDRAWN: Moxifloxacin is an effective and safe candidate agent for tuberculosis treatment: a meta-analysis.

Xu P, Chen H, Xu J, Wu M, Zhu X, Wang F, Chen S, Xu J.

Int J Infect Dis. 2015 Oct 23. pii: S1201-9712(15)00241-6. doi: 10.1016/j.ijid.2015.10.007. [Epub ahead of print]

16.

Update on a proper use of systemic fluoroquinolones in adult patients (ciprofloxacin, levofloxacin, moxifloxacin, norfloxacin, ofloxacin, pefloxacin. SPILF.).

Chidiac C; SPILF working group.

Med Mal Infect. 2015 Sep;45(9):348-73. doi: 10.1016/j.medmal.2015.07.003. Epub 2015 Oct 1. No abstract available.

PMID:
26432627
17.

Treatment of Helicobacter pylori Infection in Korea: A Systematic Review and Meta-analysis.

Lee SW, Kim HJ, Kim JG.

J Korean Med Sci. 2015 Aug;30(8):1001-9. doi: 10.3346/jkms.2015.30.8.1001. Epub 2015 Jul 15. Review.

18.

Inter-study variability of preclinical in vivo safety studies and translational exposure-QTc relationships--a PKPD meta-analysis.

Gotta V, Cools F, van Ammel K, Gallacher DJ, Visser SA, Sannajust F, Morissette P, Danhof M, van der Graaf PH.

Br J Pharmacol. 2015 Sep;172(17):4364-79. doi: 10.1111/bph.13218. Epub 2015 Jul 21.

19.

A Meta-analysis of Sequential Intravenous/Oral Moxifloxacin Monotherapy for Treatment of Skin and Skin Structure Infections.

Chu Y, Qu J, Qu LY, Luo YF, Jiang MY.

Drug Res (Stuttg). 2015 Dec;65(12):650-7. doi: 10.1055/s-0034-1398687. Epub 2015 Jun 12. Review.

PMID:
26070015
20.

Moxifloxacin plus standard first-line therapy in the treatment of pulmonary tuberculosis: A meta-analysis.

Chen Z, Liang JQ, Wang JH, Feng SS, Zhang GY.

Tuberculosis (Edinb). 2015 Jul;95(4):490-6. doi: 10.1016/j.tube.2015.03.014. Epub 2015 Apr 16. Review.

PMID:
25964137

Supplemental Content

Loading ...
Support Center